Variant report

Variant	nsv907723
Chromosome Location	chr17:16643881-16777177
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr17:16719341-16719384	H1-hESC	embryonic stem cell:	n/a	n/a
2	BACH1	chr17:16719169-16719457	K562	blood:	n/a	n/a
3	BATF	chr17:16711019-16711268	GM12878	blood:	n/a	chr17:16711188-16711198 chr17:16711187-16711198
4	BATF	chr17:16710949-16711369	GM12878	blood:	n/a	chr17:16711188-16711198 chr17:16711187-16711198
5	BATF	chr17:16648342-16648531	GM12878	blood:	n/a	n/a
6	BHLHE40	chr17:16655478-16655512	K562	blood:	n/a	n/a
7	BHLHE40	chr17:16776637-16776774	A549	lung:	n/a	n/a
8	BRCA1	chr17:16764549-16764560	Hela-S3	cervix:	n/a	n/a
9	BRCA1	chr17:16776669-16776811	H1-hESC	embryonic stem cell:	n/a	n/a
10	CEBPB	chr17:16663012-16663205	IMR90	lung:	n/a	chr17:16663087-16663100 chr17:16663087-16663100 chr17:16663087-16663098 chr17:16663087-16663100 chr17:16663089-16663098
11	CEBPB	chr17:16663026-16663220	A549	lung:	n/a	chr17:16663087-16663100 chr17:16663087-16663100 chr17:16663087-16663098 chr17:16663087-16663100 chr17:16663089-16663098
12	CEBPB	chr17:16773866-16773956	A549	lung:	n/a	n/a
13	CEBPB	chr17:16764004-16764108	HepG2	liver:	n/a	chr17:16764008-16764019
14	CEBPB	chr17:16763881-16764076	A549	lung:	n/a	chr17:16764008-16764019
15	CEBPB	chr17:16771713-16771889	HepG2	liver:	n/a	chr17:16771790-16771801
16	CEBPB	chr17:16663042-16663112	K562	blood:	n/a	chr17:16663087-16663100 chr17:16663087-16663100 chr17:16663087-16663098 chr17:16663087-16663100 chr17:16663089-16663098
17	CEBPB	chr17:16764555-16764730	Hela-S3	cervix:	n/a	n/a
18	CEBPB	chr17:16676545-16676704	Hela-S3	cervix:	n/a	n/a
19	CEBPB	chr17:16771631-16771906	A549	lung:	n/a	chr17:16771790-16771801
20	CEBPB	chr17:16763876-16764183	Hela-S3	cervix:	n/a	chr17:16764008-16764019
21	CEBPB	chr17:16768234-16768445	Hela-S3	cervix:	n/a	n/a
22	CHD2	chr17:16764544-16764744	Hela-S3	cervix:	n/a	n/a
23	CTCF	chr17:16769320-16769470	HCT-116	colon:	n/a	n/a
24	CTCF	chr17:16776640-16776790	GM12875	blood:	n/a	chr17:16776707-16776720 chr17:16776706-16776722 chr17:16776705-16776723 chr17:16776700-16776721 chr17:16776712-16776720 chr17:16776707-16776720
25	CTCF	chr17:16655072-16655235	GM10266	blood:	n/a	n/a
26	CTCF	chr17:16655176-16655510	K562	blood:	n/a	n/a
27	CTCF	chr17:16733626-16733923	A549	lung:	n/a	n/a
28	CTCF	chr17:16767753-16767979	Gliobla	brain:	n/a	n/a
29	CTCF	chr17:16769232-16769314	GM13976	blood:	n/a	chr17:16769264-16769282
30	CTCF	chr17:16764560-16764710	NHEK	skin:	n/a	n/a
31	CTCF	chr17:16764620-16764770	WERI-Rb-1	eye:	n/a	n/a
32	CTCF	chr17:16654660-16654810	A549	lung:	n/a	n/a
33	CTCF	chr17:16654649-16654825	MCF-7	breast:	n/a	n/a
34	CTCF	chr17:16654700-16654850	HCT-116	colon:	n/a	n/a
35	CTCF	chr17:16776620-16776770	GM12866	blood:	n/a	chr17:16776707-16776720 chr17:16776706-16776722 chr17:16776705-16776723 chr17:16776700-16776721 chr17:16776712-16776720 chr17:16776707-16776720
36	CTCF	chr17:16733699-16733830	GM19239	blood:	n/a	n/a
37	CTCF	chr17:16748022-16748082	GM13976	blood:	n/a	n/a
38	CTCF	chr17:16764640-16764790	RPTEC	kidney:	n/a	n/a
39	CTCF	chr17:16769155-16769327	H1-hESC	embryonic stem cell:	n/a	chr17:16769264-16769282
40	CTCF	chr17:16776620-16776770	SAEC	small airway:	n/a	chr17:16776707-16776720 chr17:16776706-16776722 chr17:16776705-16776723 chr17:16776700-16776721 chr17:16776712-16776720 chr17:16776707-16776720
41	CTCF	chr17:16654680-16654830	HCFaa	heart:	n/a	n/a
42	CTCF	chr17:16764570-16764841	NHEK	skin:	n/a	n/a
43	CTCF	chr17:16776660-16776810	HRE	kidney:	n/a	chr17:16776707-16776720 chr17:16776706-16776722 chr17:16776705-16776723 chr17:16776700-16776721 chr17:16776712-16776720 chr17:16776707-16776720
44	CTCF	chr17:16654660-16654810	HepG2	liver:	n/a	n/a
45	CTCF	chr17:16654698-16654822	MCF-7	breast:	n/a	n/a
46	CTCF	chr17:16709080-16709230	AG09319	gingival:	n/a	n/a
47	CTCF	chr17:16776541-16776862	K562	blood:	n/a	chr17:16776707-16776720 chr17:16776706-16776722 chr17:16776705-16776723 chr17:16776700-16776721 chr17:16776712-16776720 chr17:16776707-16776720
48	CTCF	chr17:16733676-16733830	H1-hESC	embryonic stem cell:	n/a	n/a
49	CTCF	chr17:16762940-16763090	HCM	heart:	n/a	n/a
50	CTCF	chr17:16693534-16693984	A549	lung:	n/a	chr17:16693765-16693786 chr17:16693771-16693787

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr17:16734819-16734869	AG09319	gingival:	n/a
2	chr17:16688816-16688866	HRPEpiC	eye:	n/a
3	chr17:16693633-16693683	NHBE	bronchial:	n/a
4	chr17:16736463-16736513	AG04450	lung:	fetal
5	chr17:16734819-16734869	RPTEC	kidney:	n/a
6	chr17:16757356-16757406	HRCEpiC	kidney:	n/a
7	chr17:16737096-16737146	HPAEpiC	pulmonary alveolar:	n/a
8	chr17:16690173-16690223	AG04449	skin:	fetal
9	chr17:16757305-16757355	HRPEpiC	eye:	n/a
10	chr17:16757356-16757406	ProgFib	skin:	n/a
11	chr17:16649246-16649296	SK-N-SH	brain:	n/a
12	chr17:16736463-16736513	Hela-S3	cervix:	n/a
13	chr17:16688816-16688866	ProgFib	skin:	n/a
14	chr17:16737096-16737146	ovcar-3	ovarian:	n/a
15	chr17:16688816-16688866	HepG2	liver:	n/a
16	chr17:16688816-16688866	SK-N-MC	brain:	n/a
17	chr17:16690169-16690219	HPAEpiC	pulmonary alveolar:	n/a
18	chr17:16737096-16737146	RPTEC	kidney:	n/a
19	chr17:16649246-16649296	HRE	kidney:	n/a
20	chr17:16690173-16690223	HAEpiC	amniotic membrane:	n/a
21	chr17:16690169-16690219	K562	blood:	n/a
22	chr17:16690173-16690223	AG10803	skin:	n/a
23	chr17:16757305-16757355	BJ	skin:	n/a
24	chr17:16757356-16757406	PrEC	prostate:	n/a
25	chr17:16734819-16734869	ovcar-3	ovarian:	n/a
26	chr17:16688816-16688866	GM12891	blood:	n/a
27	chr17:16693633-16693683	HL-60	blood:	n/a
28	chr17:16690169-16690219	HNPCEpiC	eye:	n/a
29	chr17:16693633-16693683	HepG2	liver:	n/a
30	chr17:16690173-16690223	AG09309	skin:	n/a
31	chr17:16690169-16690219	IMR90	lung:	fetal
32	chr17:16693633-16693683	HCPEpiC	choroid plexus:	n/a
33	chr17:16693633-16693683	K562	blood:	n/a
34	chr17:16736463-16736513	AG04449	skin:	fetal
35	chr17:16757305-16757355	HMEC	breast:	n/a
36	chr17:16690173-16690223	LNCaP	prostate:	n/a
37	chr17:16757305-16757355	Jurkat	blood:	n/a
38	chr17:16688816-16688866	Hela-S3	cervix:	n/a
39	chr17:16734819-16734869	HUVEC	blood vessel:	n/a
40	chr17:16690169-16690219	MCF10A-Er-Src	breast:	n/a
41	chr17:16688816-16688866	A549	lung:	n/a
42	chr17:16690173-16690223	AG04450	lung:	fetal
43	chr17:16693633-16693683	T-47D	breast:	n/a
44	chr17:16690173-16690223	HIPEpiC	eye:	n/a
45	chr17:16688816-16688866	HCF	heart:	n/a
46	chr17:16690173-16690223	HCPEpiC	choroid plexus:	n/a
47	chr17:16757305-16757355	RPTEC	kidney:	n/a
48	chr17:16736463-16736513	HCM	heart:	n/a
49	chr17:16757356-16757406	GM06990	blood:	n/a
50	chr17:16757356-16757406	AG04449	skin:	fetal

No.	Distal block	Cell Line	Cell type
1	chr17:16721818..16722353-chr17:16776583..16777108,2	MCF-7	breast:
2	chr17:16756059..16758999-chr17:16760586..16763495,2	K562	blood:
3	chr17:16721818..16722353-chr17:16776583..16777108,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-KRT17P1-2	chr17:16750949-16751252	NONHSAT146019
2	lnc-CCDC144A-4	chr17:16734662-16734742	NONHSAT146016
3	lnc-KRT17P1-2	chr17:16751411-16751727	NONHSAT146019
4	lnc-CCDC144A-4	chr17:16735634-16735881	NONHSAT146016
5	lnc-AC104024.2.1-3	chr17:16692215-16692721	NONHSAT146007
6	lnc-KRT17P1-1	chr17:16691922-16692548	ENSG00000264673.1
7	lnc-AC104024.2.1-3	chr17:16692057-16693815	NONHSAT146006
8	lnc-CCDC144A-1	chr17:16707941-16707992	ENSG00000264729.1
9	lnc-CCDC144A-1	chr17:16708772-16709021	ENSG00000264729.1
10	lnc-KRT17P1-1	chr17:16691562-16691620	ENSG00000264673.1

No.	miRNA target gene	miRNA name	Chromosome Location	mirBase accession
1	LOC162632	hsa-miR-26b-5p	chr17:16707023-16707045
2	CCDC144A	hsa-miR-26b-5p	chr17:16677653-16677674

Variant related genes	Relation type
ENSG00000205312	TF binding region
ENSG00000226145	TF binding region
UPF3AP1	TF binding region
KRT16P2	TF binding region
FAM106CP	TF binding region
ENSG00000264673	TF binding region
COTL1P1	TF binding region
USP32P1	TF binding region
ENSG00000272815	TF binding region
SRP68P1	TF binding region
ENSG00000264892	TF binding region
KRT17P1	TF binding region
ENSG00000264729	TF binding region
ENSG00000205312	CpG island
ENSG00000226145	CpG island
UPF3AP1	CpG island
KRT16P2	CpG island
FAM106CP	CpG island
ENSG00000264673	CpG island
COTL1P1	CpG island
USP32P1	CpG island
ENSG00000272815	CpG island
SRP68P1	CpG island
ENSG00000264892	CpG island
KRT17P1	CpG island
ENSG00000264729	CpG island
ENSG00000205312	chromatin interactions
ENSG00000229749	chromatin interactions

Extended variants
information (count: 3467 )
Associated
traits (count: 161 )

Variant overlapped rSNPs/rCNVs (count:3467 , 50 per page) page: 1 2 3 4 5 6 7 ... 70

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs4094443	chr17:16645067-16645068	Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs531843059	chr17:16645102-16645103	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs552026862	chr17:16645105-16645106	Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs2621542	chr17:16645141-16645142	Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs113461815	chr17:16645191-16645192	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs199836987	chr17:16645195-16645196	Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs528259261	chr17:16648210-16648211	Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
8	rs4034562	chr17:16648217-16648218	Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
9	rs4034563	chr17:16648221-16648222	Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
10	rs149240058	chr17:16648233-16648234	Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
11	rs374124286	chr17:16648247-16648248	Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
12	rs2621534	chr17:16648282-16648283	Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
13	rs4034565	chr17:16648287-16648288	Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
14	rs563453081	chr17:16648295-16648296	Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
15	rs536963472	chr17:16648320-16648321	Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
16	rs2260298	chr17:16648341-16648342	Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
17	rs2349270	chr17:16648345-16648346	Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
18	rs1847577	chr17:16648350-16648351	Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
19	rs184106405	chr17:16648355-16648356	Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
20	rs559085048	chr17:16648376-16648377	Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
21	rs564036835	chr17:16648856-16648857	Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs576759110	chr17:16648862-16648863	Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs545431254	chr17:16648882-16648883	Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs558981208	chr17:16648890-16648891	Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs528173289	chr17:16648919-16648920	Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs201163615	chr17:16648978-16648979	Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs541592457	chr17:16648999-16649000	Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs561530952	chr17:16649011-16649012	Active TSS Bivalent/Poised TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs144648733	chr17:16649032-16649033	Active TSS Bivalent/Poised TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs550600373	chr17:16649229-16649230	Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
31	rs12449564	chr17:16649232-16649233	Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
32	rs2621532	chr17:16649235-16649236	Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
33	rs562614135	chr17:16649238-16649239	Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
34	rs532362390	chr17:16649246-16649247	Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
35	rs552609505	chr17:16649273-16649274	Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
36	rs566150872	chr17:16649279-16649280	Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
37	rs2586647	chr17:16649281-16649282	Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
38	rs187379561	chr17:16649287-16649288	Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
39	rs114491844	chr17:16649289-16649290	Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
40	rs568538666	chr17:16649300-16649301	Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
41	rs2543782	chr17:16649304-16649305	Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
42	rs537696483	chr17:16649333-16649334	Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
43	rs557358473	chr17:16649378-16649379	Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
44	rs2621531	chr17:16649385-16649386	Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
45	rs577472430	chr17:16649395-16649396	Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
46	rs545345304	chr17:16649424-16649425	Active TSS Bivalent/Poised TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs2586646	chr17:16649428-16649429	Active TSS Bivalent/Poised TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs559663304	chr17:16649462-16649463	Active TSS Bivalent/Poised TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs552568920	chr17:16649479-16649480	Active TSS Bivalent/Poised TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs370181880	chr17:16649585-16649586	Active TSS Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:161)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Burkitt''s lymphoma	19759907	CNVD
Wilms tumour	21544195	CNVD
Esophageal adenocarcinoma	18519675	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Chordoma	21602918	CNVD
Miller-Dieker syndrome	22283845	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Cancer	22429812	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Ewing''s sarcoma	21437220	CNVD
Follicular lymphoma	19010834	CNVD
Colorectal cancer	20709793	CNVD
Acute myeloid leukemia	16864856	CNVD
Endometrial cancer	22040021	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Breast cancer	22028636	CNVD
Breast cancer	20837533	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
colon cancer	17210682	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Basal cell lymphoma	17053054	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Cancer	16751803	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Chronic lymphocytic leukemia	17971485	CNVD
Basal cell lymphoma	17170743	CNVD
Breast cancer	16461572	CNVD
Colorectal cancer	16272173	CNVD
Follicular lymphoma	17170743	CNVD
Human rectal carcinomas	16397240	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	17133270	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Moyamoya disease	22323933	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	21251322	CNVD
Myelodysplastic syndrome	21251322	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20724749	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Acute myeloid leukemia	17237825	CNVD
Colorectal cancer	21645411	CNVD
HIV/AIDS	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
HIV/AIDS	17953491	CNVD
HIV/AIDS	20877625	CNVD
Immune disease	21076436	CNVD
Rheumatoid arthritis	17953491	CNVD
Type 1 diabetes	17953491	CNVD
HIV/AIDS	15637236	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21781307	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Neurofibromatosis	18196300	CNVD
Adenoid cystic carcinoma	18332873	CNVD
Colorectal cancer	16774939	CNVD
Pancreatic cancer	21811587	CNVD
Breast cancer	17001317	CNVD
Rhabdomyosarcoma	16790082	CNVD
Charcot-marie-tooth disease	16463004	CNVD
Osteosarcoma	22292074	CNVD
Breast cancer	17603634	CNVD
Charcot	16760730	CNVD
Mental retardation	17901693	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
ovarian endometriomas	16273235	CNVD
Ovarian cancer	21720365	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Gastric cancer	18160780	CNVD
Smith-Magenis syndrome	18923513	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16272173	CNVD
Austim spectrum disorder	21302340	CNVD
Autism	22492990	CNVD
Congenital abnormalities	21549014	CNVD
Developmental delay	18414209	CNVD
Developmental delay	21549014	CNVD
Epilepsy	20970697	CNVD
Mental retardation	18414209	CNVD
Mental retardation	21549014	CNVD
Smith-Magenis syndrome	21981782	CNVD
Smith-Magenis syndrome	20188345	CNVD
Smith-Magenis syndrome	16775514	CNVD
Smith-Magenis syndrome	22585170	CNVD
Smith-Magenis syndrome	22241247	CNVD
Autism	20970697	CNVD
Mental retardation	19951919	CNVD
Potocki-Lupski syndrome	21271655	CNVD
Potocki-lupski syndrome	17357070	CNVD
Potocki-lupski syndrome	20110824	CNVD
Potocki-lupski syndrome	18923514	CNVD
Potocki-lupski syndrome	22241247	CNVD
Potocki-lupski syndrome	20188345	CNVD
Schizophrenia	21399695	CNVD
Mental retardation	16773131	CNVD
Adenocarcinoma	19607727	CNVD
Squamous cell cancer	19607727	CNVD
Non-small cell lung cancer	21829676	CNVD
Glioblastoma multiforme	17002787	CNVD
Charcot-marie-tooth disease	22470819	CNVD
Neurofibromatosis	22470819	CNVD
Neuropathy	22470819	CNVD
Smith-Magenis syndrome	18301319	CNVD
Smith-Magenis syndrome	17357070	CNVD
Smith-Magenis syndrome	18469339	CNVD
Smith-Magenis syndrome	22241097	CNVD
Smith-Magenis syndrome	22470819	CNVD
Tourette syndrome	18923514	CNVD
Type 1 diabetes	22470819	CNVD
Potocki-lupski syndrome	18469339	CNVD
Follicular lymphoma	20505157	CNVD
T-cell lymphomas	19863542	CNVD
Neuropathy	17597781	CNVD
Hepatocellular carcinoma	16750200	CNVD
Neurodevelopmental disorder	17015230	CNVD
Smith-Magenis syndrome	17597781	CNVD
Potocki-lupski syndrome	18059269	CNVD
Potocki-lupski syndrome	17597781	CNVD
Mental retardation	17847001	CNVD
Multiple myeloma	16616336	CNVD
Breast cancer	20409316	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Breast cancer	21509527	CNVD
Ductal carcinoma	22052326	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Multiple myeloma	17550852	CNVD

Chromatin state (count:432 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:16645000-16645200	Enhancers	Primary monocytes fromperipheralblood	blood
2	chr17:16648200-16648400	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
3	chr17:16648800-16649600	Active TSS	iPS-15b Cell Line	embryonic stem cell
4	chr17:16649000-16649400	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
5	chr17:16649000-16649400	Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
6	chr17:16649000-16649400	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
7	chr17:16649000-16649400	Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
8	chr17:16649000-16649600	Active TSS	H1 Cell Line	embryonic stem cell
9	chr17:16649000-16649600	Active TSS	HUES6 Cell Line	embryonic stem cell
10	chr17:16649000-16649600	Active TSS	iPS-18 Cell Line	embryonic stem cell
11	chr17:16649000-16649800	Active TSS	HUES48 Cell Line	embryonic stem cell
12	chr17:16649000-16650000	Active TSS	H9 Cell Line	embryonic stem cell
13	chr17:16649000-16650000	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
14	chr17:16649200-16649400	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
15	chr17:16649200-16649400	Bivalent Enhancer	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
16	chr17:16649200-16649400	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung
17	chr17:16649200-16649400	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
18	chr17:16649200-16649400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
19	chr17:16649200-16649400	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
20	chr17:16649200-16649400	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin03	Skin
21	chr17:16649200-16649400	Bivalent/Poised TSS	Foreskin Melanocyte Primary Cells skin03	Skin
22	chr17:16649200-16649400	Bivalent Enhancer	Primary mononuclear cells fromperipheralblood	Blood
23	chr17:16649200-16649400	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
24	chr17:16649200-16649400	Flanking Bivalent TSS/Enh	Fetal Brain Female	brain
25	chr17:16649200-16649400	Bivalent Enhancer	Fetal Kidney	kidney
26	chr17:16649200-16649400	Bivalent Enhancer	Fetal Lung	lung
27	chr17:16649200-16649400	Bivalent Enhancer	Fetal Muscle Leg	muscle
28	chr17:16649200-16649400	Bivalent Enhancer	Rectal Mucosa Donor 31	rectum
29	chr17:16649200-16649400	Bivalent Enhancer	HSMM	muscle
30	chr17:16649200-16649600	Bivalent/Poised TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
31	chr17:16649200-16649600	Active TSS	Brain Anterior Caudate	brain
32	chr17:16649200-16649600	Active TSS	Brain Cingulate Gyrus	brain
33	chr17:16649200-16649800	Active TSS	ES-I3 Cell Line	embryonic stem cell
34	chr17:16649400-16649600	Enhancers	Primary T helper cells PMA-I stimulated	--
35	chr17:16649400-16649600	Bivalent/Poised TSS	Fetal Brain Female	brain
36	chr17:16649400-16650000	Active TSS	iPS-20b Cell Line	embryonic stem cell
37	chr17:16650000-16650200	Flanking Active TSS	Breast Myoepithelial Primary Cells	Breast
38	chr17:16652200-16653400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
39	chr17:16652400-16652600	Enhancers	Muscle Satellite Cultured Cells	--
40	chr17:16653200-16653600	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
41	chr17:16653200-16654600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
42	chr17:16653400-16654200	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
43	chr17:16653600-16654000	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
44	chr17:16654000-16655200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
45	chr17:16654200-16654400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
46	chr17:16654200-16654600	Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
47	chr17:16654200-16654600	Enhancers	NHEK	skin
48	chr17:16654200-16654800	Enhancers	NH-A	brain
49	chr17:16654200-16655000	Enhancers	Dnd41	blood
50	chr17:16654200-16655000	Enhancers	Osteobl	bone

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links